晚期慢性阻塞性肺病中的呼吸障碍和息护理:快速审查
概括
慢性阻塞性肺病 (COPD) 呼吸障碍症的息护理 (PC) 干预措施未得到充分利用和了解. 早期整合PC和澄清阿片类药物使用可以改善COPD症状管理.
科学领域:
- 肺部医学 肺部医学
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 呼吸不良是慢性阻塞性肺病 (COPD) 中的主要活动限制症状.
- 尽管有建议,但COPD呼吸障碍的息护理 (PC) 尚未得到充分利用,干预措施不太了解.
- 由于COPD治疗的复杂性,需要探索PC的作用.
研究的目的:
- 探索呼吸障碍的概念和PC在COPD管理中的作用.
- 从提供者,护理人员和患者的角度检查呼吸障碍的运行,管理策略和PC影响.
- 为了确定在COPD护理中PC整合的障碍和促进者.
主要方法:
- 快速审查方法系统地综合了13篇文章 (2018年1月-2023年10月).
- 通过可视化和主题聚类进行数据合成,以确定关键结论.
- 通过多个利益相关方的透视来探索呼吸障碍和PC.
主要成果:
- 由于测量和术语不一致,COPD中呼吸障碍的运行具有挑战性.
- 阿片类药物治疗对于呼吸障碍是常见的,但受到提供者偏见和患者/护理人员看法的影响.
- 呼吸障碍的严重负担使COPD治疗复杂化.
结论:
- 需要基于证据的指导方针来澄清阿片类药物用于呼吸障碍,减少耻辱和治疗障碍.
- 提供者教育强调多方面的方法和早期PC整合对于COPD呼吸障碍管理至关重要.
- 提高PC干预措施的理解和应用可以提高COPD患者的治疗结果.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195


